
|Videos|July 12, 2016
- Gastrointestinal Cancers: mCRC (Issue 9)
- Volume 1
- Issue 9
Overview of the Lume 1 and 2 Trials
Author(s)Axel Grothey, MD
Axel Grothey, MD, Mayo Clinic in Rochester, Minnesota, discusses the Lume 1 and 2 trials as well as new treatment options for metastatic colorectal cancer.
Articles in this issue
almost 10 years ago
Role of DPR in Colorectal Canceralmost 10 years ago
Impact of HER2 Amplification in Colorectal Canceralmost 10 years ago
Tumor Location Findings Shed Light on CALGB/SWOG 80405, FIRE-3 Discrepancyalmost 10 years ago
Novel Immunotherapy Combinations on Horizon for mCRCalmost 10 years ago
SIRT Added to First-line Chemo Improves Response in Colorectal Cancer






























